University of Florida
Hematology and Oncology fellowship · Gainesville, FL · University of Florida programs · Program website
Internal Medicine residency here · Other fellowships: Rheumatology · Cardiovascular Disease · Gastroenterology · Pulmonary and Critical Care · Nephrology · Infectious Disease · Endocrinology, Diabetes, and Metabolism · Geriatric Medicine
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is University of Florida's research in hematology and oncology, which the program shares with other departments and affiliated hospitals.
Hematology and Oncology at University of Floridashared by every program there, not this program's own
Institution-level: all hematology and oncology publications from University of Florida and affiliated institutions, since 2022. Updated 2026-11-09; refreshed daily.
Works per year · * 2026 so far
Hematology and Oncology research topics at University of Florida
Papers in the window; each links to the list on OpenAlex.
- Glioma Diagnosis and Treatment 125
- Sarcoma Diagnosis and Treatment 106
- Pancreatic and Hepatic Oncology Research 101
- Cancer Immunotherapy and Biomarkers 86
- Acute Myeloid Leukemia Research 76
- Hematopoietic Stem Cell Transplantation 74
- Cutaneous Melanoma Detection and Management 68
- Viral-associated cancers and disorders 61
Most cited at University of Florida since 2024
All hematology and oncology papers there on OpenAlex
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 183
- SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockadeAdam Grippin et al. · Nature · 2025 · PubMed · cited 155
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 516
- Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD –mutated AMLMark J. Levis et al. · Blood · 2025 · PubMed · cited 66
- Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in ChildrenSumit Gupta et al. · New England Journal of Medicine · 2024 · PubMed · cited 253
- American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the diagnosis and management of solid pancreatic masses: summary and recommendationsJorge D. Machicado et al. · Gastrointestinal Endoscopy · 2024 · PubMed · cited 61
- Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group studySusan R. Rheingold et al. · Leukemia · 2024 · PubMed · cited 92
- Iron homeostasis in older adults: balancing nutritional requirements and health risksRola S Zeidan et al. · The journal of nutrition health & aging · 2024 · PubMed · cited 60
- Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3Mark J. Levis et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 237
- Oral iron therapy: Current concepts and future prospects for improving efficacy and outcomesPearl Onuwa Ebea et al. · British Journal of Haematology · 2024 · PubMed · cited 68
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/university-florida-college-medicine-heme-onc"><img src="https://openprograms.org/programs/university-florida-college-medicine-heme-onc/badge.svg" alt="University of Florida Hematology and Oncology fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.